Sotac Pharmaceuticals opened lower at -, compared with its previous close of ₹90.05. In the last trading session on 1 Oct 2026, the stock traded between - and -, with an average traded price of -. It showed a sideways intraday trend.
return calculator
Time Period
An investment of ₹10,000 made 4 years ago in Sotac Pharmaceuticals is now worth
₹ 7,697.00
resulting in a loss of
₹ 2,303.00 (23.03%)
invest now
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+0.00 (+0.00%)
Day High
-
Day Low
-
Day Open
-
Prev Close
₹90.05
Volume
-
Value Traded
-
1W Return
0.00%
1M Return
-2.07%
3M Return
-10.40%
6M Return
-11.72%
1Y Return
-27.96%
Fundamentals
Market Cap (₹ Cr.)
100
PE Ratio
15.80
PB Ratio
1.69
Dividend Yield
0.22%
ROE
9.75%
ROCE
17.07%
Book Value (₹)
53.28
Face Value (₹)
10.00
EPS (TTM)
0.42
Industry PE
-
Beta
-
Debt to Equity
-
Investment Returns
1 Week
0.00%
6 Week
-
1 Month
-2.07%
3 Month
-10.40%
9 Month
-19.67%
Financials
Yearly
Consolidated
All values in ₹ crores
0.29
Mar 20
0.49
Mar 21
0.78
Mar 23
1.04
Mar 24
1.01
Mar 25
1.02
Mar 26
Share Holding Pattern
Promoter72.85%
FII16.79%
DII0.00%
Retails & Others6.52%
Updates
27May
Sotac Pharmaceuticals FY26 Net Profit at ₹576.67 Lakh; Dividend of ₹0.20 Per Share Declared
Sotac Pharmaceuticals reported a consolidated net profit of ₹576.67 lakh for FY26 on revenue from operations of ₹10,123.93 lakh, with consolidated EPS at ₹5.22. Standalone net profit improved to ₹491.82 lakh on revenue of ₹7,187.95 lakh. The board recommended a final dividend of ₹0.20 per equity share, subject to shareholder approval, and statutory auditors issued an unmodified opinion on both standalone and consolidated results.
